Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans.

Wright PF, Karron RA, Madhi SA, Treanor JJ, King JC, O'Shea A, Ikizler MR, Zhu Y, Collins PL, Cutland C, Randolph VB, Deatly AM, Hackell JG, Gruber WC, Murphy BR.

J Infect Dis. 2006 Feb 15;193(4):573-81. Epub 2006 Jan 19.

2.

Clinical experience with respiratory syncytial virus vaccines.

Piedra PA.

Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S94-9. Review.

PMID:
12671459
3.

Respiratory syncytial virus vaccines: can we improve on nature?

Tristram DA, Welliver RC.

Pediatr Ann. 1993 Dec;22(12):715-8. Review.

PMID:
8139872
4.

Immunopathology of RSV infection: prospects for developing vaccines without this complication.

van Drunen Littel-van den Hurk S, Mapletoft JW, Arsic N, Kovacs-Nolan J.

Rev Med Virol. 2007 Jan-Feb;17(1):5-34. Review.

PMID:
17004293
5.

Human and bovine respiratory syncytial virus vaccine research and development.

Meyer G, Deplanche M, Schelcher F.

Comp Immunol Microbiol Infect Dis. 2008 Mar;31(2-3):191-225. Epub 2007 Aug 27. Review.

PMID:
17720245
6.

The non-structural proteins of RSV: targeting interferon antagonists for vaccine development.

Teng MN.

Infect Disord Drug Targets. 2012 Apr;12(2):129-37. Review.

PMID:
22335499
7.

Respiratory syncytial virus vaccines for otitis media.

Anderson LJ.

Vaccine. 2000 Dec 8;19 Suppl 1:S59-65. Review.

PMID:
11163465
8.

Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics.

Collins PL, Whitehead SS, Bukreyev A, Fearns R, Teng MN, Juhasz K, Chanock RM, Murphy BR.

Adv Virus Res. 1999;54:423-51. Review.

PMID:
10547682
9.
10.

Advances in respiratory syncytial virus vaccine development.

Kneyber MC, Kimpen JL.

Curr Opin Investig Drugs. 2004 Feb;5(2):163-70. Review.

PMID:
15043390
11.

Respiratory syncytial virus mechanisms to interfere with type 1 interferons.

Barik S.

Curr Top Microbiol Immunol. 2013;372:173-91. doi: 10.1007/978-3-642-38919-1_9. Review.

PMID:
24362690
12.

Respiratory syncytial virus infection in adults.

Falsey AR.

Semin Respir Crit Care Med. 2007 Apr;28(2):171-81. Review.

PMID:
17458771
14.

Respiratory syncytial virus vaccines.

Dudas RA, Karron RA.

Clin Microbiol Rev. 1998 Jul;11(3):430-9. Review.

15.

Respiratory syncytial virus infection in adults.

Murata Y, Falsey AR.

Antivir Ther. 2007;12(4 Pt B):659-70. Review.

PMID:
17944273
16.
17.

Challenges in developing a pediatric RSV vaccine.

Schickli JH, Dubovsky F, Tang RS.

Hum Vaccin. 2009 Sep;5(9):582-91. Epub 2009 Sep 28. Review.

PMID:
19556888
18.
19.

Current concepts on active immunization against respiratory syncytial virus for infants and young children.

Kneyber MC, Kimpen JL.

Pediatr Infect Dis J. 2002 Jul;21(7):685-96. Review.

PMID:
12237605
20.

Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease.

Castilow EM, Olson MR, Varga SM.

Immunol Res. 2007;39(1-3):225-39. Review.

PMID:
17917067
Items per page

Supplemental Content

Write to the Help Desk